The Surrey CRC is a core human research resource within the Faculty of Health & Medical Sciences, University of Surrey.
The quality vaccine research funded by the EUR 30 million FP7 High Impact Project on Advanced Immunization Technologies (ADITEC) is confirmed by the bibliometric analysis of the scientific papers produced by the project.
We are pleased to announce that Surrey CRC was once again awarded MHRA Phase I accreditation in December 2014.
The Surrey Clinical Research Centre was recently at the centre of an international effort with European Commission funding to design and test a vaccine to prevent HIV/AIDS.
We are excited to announce the commencement of a cutting edge Phase 1 study deploying a live genetically modified virus to treat cancer patients with advanced solid tumours.